Manufacturers Life Insurance Company, The Praxis Precision Medicines, Inc. Transaction History

Manufacturers Life Insurance Company, The

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $25,763 - $166,947	-14,722 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$10.21 - $20.29 $150,311 - $298,709	14,722 New	14,722 $150,000
Q1 2022 May 20, 2022	SELL	$10.21 - $20.29 $33,744 - $67,058	-3,305 Reduced 18.33%	14,722 $150,000
Q4 2021 Feb 16, 2022	BUY	$16.76 - $22.99 $4,223 - $5,793	252 Added 1.42%	18,027 $355,000
Q3 2021 Nov 12, 2021	BUY	$13.15 - $22.56 $42,500 - $72,913	3,232 Added 22.22%	17,775 $329,000
Q2 2021 Aug 12, 2021	BUY	$18.28 - $33.05 $149,603 - $270,481	8,184 Added 128.7%	14,543 $266,000
Q1 2021 May 03, 2021	SELL	$29.34 - $60.2 $88 - $180	-3 Reduced 0.05%	6,359 $208,000
Q4 2020 Feb 12, 2021	BUY	$27.25 - $55.82 $173,364 - $355,126	6,362 New	6,362 $350,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.